Pharmacological characterization of cerebrovascular cholinergic receptors: combined biochemical and physiological approach.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology; D002415:Cats; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D015237:Dinoprost; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D008688:Methacholine Compounds; D011460:Prostaglandins F; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; C028484:quinuclidinyl benzilate receptor; D010643:Phenoxybenzamine; D016210:Methacholine Chloride; D011813:Quinuclidinyl Benzilate; D002217:Carbachol; D015237:Dinoprost; D000109:Acetylcholine